Literature DB >> 28583723

Control of B lymphocyte development and functions by the mTOR signaling pathways.

Terri N Iwata1, Julita A Ramírez-Komo1, Heon Park1, Brian M Iritani2.   

Abstract

Mechanistic target of rapamycin (mTOR) is a serine/threonine kinase originally discovered as the molecular target of the immunosuppressant rapamycin. mTOR forms two compositionally and functionally distinct complexes, mTORC1 and mTORC2, which are crucial for coordinating nutrient, energy, oxygen, and growth factor availability with cellular growth, proliferation, and survival. Recent studies have identified critical, non-redundant roles for mTORC1 and mTORC2 in controlling B cell development, differentiation, and functions, and have highlighted emerging roles of the Folliculin-Fnip protein complex in regulating mTOR and B cell development. In this review, we summarize the basic mechanisms of mTOR signaling; describe what is known about the roles of mTORC1, mTORC2, and the Folliculin/Fnip1 pathway in B cell development and functions; and briefly outline current clinical approaches for targeting mTOR in B cell neoplasms. We conclude by highlighting a few salient questions and future perspectives regarding mTOR in B lineage cells.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B lymphocyte development; Fnip1; Folliculin; mTOR

Mesh:

Substances:

Year:  2017        PMID: 28583723      PMCID: PMC5559228          DOI: 10.1016/j.cytogfr.2017.04.005

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  148 in total

Review 1.  B cell antigen receptor signaling 101.

Authors:  Joseph M Dal Porto; Stephen B Gauld; Kevin T Merrell; David Mills; Aimee E Pugh-Bernard; John Cambier
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

2.  [Activation and clinicopathologic significance of AKT/mTOR signaling pathway in diffuse large B-cell lymphoma].

Authors:  Bao-hua Yu; Xiao-yan Zhou; Xiu-ying Xiao; Shi-yan Yan; Tao Qin; Da-ren Shi
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2009-01

3.  Identification and characterization of a novel folliculin-interacting protein FNIP2.

Authors:  Hisashi Hasumi; Masaya Baba; Seung-Beom Hong; Yukiko Hasumi; Ying Huang; Masahiro Yao; Vladimir A Valera; W Marston Linehan; Laura S Schmidt
Journal:  Gene       Date:  2008-03-04       Impact factor: 3.688

4.  Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62/sequestosome 1.

Authors:  Shengbing Huang; Zhineng J Yang; Chunrong Yu; Frank A Sinicrope
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

Review 5.  The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.

Authors:  Michelle C Mendoza; E Emrah Er; John Blenis
Journal:  Trends Biochem Sci       Date:  2011-04-30       Impact factor: 13.807

6.  regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis.

Authors:  Jae Eun Kim; Jie Chen
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

Review 7.  Regulation of innate immune cell function by mTOR.

Authors:  Thomas Weichhart; Markus Hengstschläger; Monika Linke
Journal:  Nat Rev Immunol       Date:  2015-10       Impact factor: 53.106

8.  Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.

Authors:  Yukiko Hasumi; Masaya Baba; Hisashi Hasumi; Ying Huang; Martin Lang; Rachel Reindorf; Hyoung-bin Oh; Sebastiano Sciarretta; Kunio Nagashima; Diana C Haines; Michael D Schneider; Robert S Adelstein; Laura S Schmidt; Junichi Sadoshima; W Marston Linehan
Journal:  Hum Mol Genet       Date:  2014-06-06       Impact factor: 6.150

Review 9.  mTOR Links Environmental Signals to T Cell Fate Decisions.

Authors:  Nicole M Chapman; Hongbo Chi
Journal:  Front Immunol       Date:  2015-01-20       Impact factor: 7.561

10.  Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.

Authors:  Jessica Okosun; Rachel L Wolfson; Jun Wang; Shamzah Araf; Lucy Wilkins; Brian M Castellano; Leire Escudero-Ibarz; Ahad Fahad Al Seraihi; Julia Richter; Stephan H Bernhart; Alejo Efeyan; Sameena Iqbal; Janet Matthews; Andrew Clear; José Afonso Guerra-Assunção; Csaba Bödör; Hilmar Quentmeier; Christopher Mansbridge; Peter Johnson; Andrew Davies; Jonathan C Strefford; Graham Packham; Sharon Barrans; Andrew Jack; Ming-Qing Du; Maria Calaminici; T Andrew Lister; Rebecca Auer; Silvia Montoto; John G Gribben; Reiner Siebert; Claude Chelala; Roberto Zoncu; David M Sabatini; Jude Fitzgibbon
Journal:  Nat Genet       Date:  2015-12-21       Impact factor: 38.330

View more
  18 in total

Review 1.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

2.  Induction of metabolic quiescence defines the transitional to follicular B cell switch.

Authors:  Jocelyn R Farmer; Hugues Allard-Chamard; Na Sun; Maimuna Ahmad; Alice Bertocchi; Vinay S Mahajan; Toby Aicher; Johan Arnold; Mark D Benson; Jordan Morningstar; Sara Barmettler; Grace Yuen; Samuel J H Murphy; Jolan E Walter; Musie Ghebremichael; Alex K Shalek; Facundo Batista; Robert Gerszten; Shiv Pillai
Journal:  Sci Signal       Date:  2019-10-22       Impact factor: 8.192

3.  PI3K Isoforms in B Cells.

Authors:  Elissa K Deenick; Julia Bier; Anthony Lau
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

4.  Conditional deletion of mTOR discloses its essential role in early B-cell development.

Authors:  Shuling Zhang; Wendy Dubois; Xingmin Feng; Joe T Nguyen; Neal S Young; Beverly A Mock
Journal:  Mol Carcinog       Date:  2021-12-29       Impact factor: 5.139

5.  Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3.

Authors:  Julita A Ramírez; Terri Iwata; Heon Park; Mark Tsang; Janella Kang; Katy Cui; Winnie Kwong; Richard G James; Masaya Baba; Laura S Schmidt; Brian M Iritani
Journal:  J Immunol       Date:  2019-11-01       Impact factor: 5.422

6.  The pro-oxidant adaptor p66SHC promotes B cell mitophagy by disrupting mitochondrial integrity and recruiting LC3-II.

Authors:  Anna Onnis; Valentina Cianfanelli; Chiara Cassioli; Dijana Samardzic; Pier Giuseppe Pelicci; Francesco Cecconi; Cosima T Baldari
Journal:  Autophagy       Date:  2018-09-06       Impact factor: 16.016

7.  mTOR intersects antibody-inducing signals from TACI in marginal zone B cells.

Authors:  Jordi Sintes; Maurizio Gentile; Shuling Zhang; Yolanda Garcia-Carmona; Giuliana Magri; Linda Cassis; Daniel Segura-Garzón; Alessandra Ciociola; Emilie K Grasset; Sabrina Bascones; Laura Comerma; Marc Pybus; David Lligé; Irene Puga; Cindy Gutzeit; Bing He; Wendy DuBois; Marta Crespo; Julio Pascual; Anna Mensa; Juan Ignacio Aróstegui; Manel Juan; Jordi Yagüe; Sergi Serrano; Josep Lloreta; Eric Meffre; Michael Hahne; Charlotte Cunningham-Rundles; Beverly A Mock; Andrea Cerutti
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

Review 8.  Regulation of Energy Metabolism during Early B Lymphocyte Development.

Authors:  Sophia Urbanczyk; Merle Stein; Wolfgang Schuh; Hans-Martin Jäck; Dimitrios Mougiakakos; Dirk Mielenz
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

9.  HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease.

Authors:  Sarah A Cook; William A Comrie; M Cecilia Poli; Morgan Similuk; Andrew J Oler; Aiman J Faruqi; Douglas B Kuhns; Sheng Yang; Alexander Vargas-Hernández; Alexandre F Carisey; Benjamin Fournier; D Eric Anderson; Susan Price; Margery Smelkinson; Wadih Abou Chahla; Lisa R Forbes; Emily M Mace; Tram N Cao; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Jordan S Orange; Geoffrey D E Cuvelier; Moza Al Hassani; Nawal Al Kaabi; Zain Al Yafei; Soma Jyonouchi; Nikita Raje; Jason W Caldwell; Yanping Huang; Janis K Burkhardt; Sylvain Latour; Baoyu Chen; Gehad ElGhazali; V Koneti Rao; Ivan K Chinn; Michael J Lenardo
Journal:  Science       Date:  2020-07-10       Impact factor: 47.728

10.  miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection.

Authors:  Marina de Assis Souza; Eduardo Milton Ramos-Sanchez; Sandra Márcia Muxel; Dimitris Lagos; Luiza Campos Reis; Valéria Rêgo Alves Pereira; Maria Edileuza Felinto Brito; Ricardo Andrade Zampieri; Paul Martin Kaye; Lucile Maria Floeter-Winter; Hiro Goto
Journal:  Front Cell Infect Microbiol       Date:  2021-06-10       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.